Skin Carcinoma Clinical Trial
— SMARTOfficial title:
Self-Monitoring and Readiness Texting Project (SMART)
Verified date | July 2018 |
Source | Fox Chase Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.
Status | Completed |
Enrollment | 114 |
Est. completion date | December 31, 2014 |
Est. primary completion date | July 30, 2014 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 29 Years |
Eligibility |
Inclusion Criteria: - Women from the Philadelphia metropolitan area who own a mobile phone and who meet criteria for at least moderate risk of skin cancer based on a brief risk assessment tool |
Country | Name | City | State |
---|---|---|---|
United States | Fox Chase Cancer Center | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Fox Chase Cancer Center | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in ultraviolet radiation (UV) exposure and sun protection behaviors based on behavior tracking and individually tailored daily text messages | Multiple variable regression models will be performed to examine the effect of the intervention on the outcomes. All post-baseline outcomes will be used as dependent variables. The baseline scores, intervention group, and time of the assessment will be included. To account for the within subject correlation of the responses, we will fit the model using Generalized Estimating Equations assuming an autoregressive working correlation matrix for each subject. Any p-value from the pairwise comparison that is less than 0.05 will be considered worthy of further study. | Baseline to up to 2 weeks | |
Secondary | Mediators and moderators of the intervention on behavior | Mediation will be assessed by examining indirect effects, with bootstrapped confidence intervals to be calculated around the mediated effects. For participants who use the self-monitoring app, hierarchical linear modeling will be used to examine associations between tanning and sun protection as they occur daily, and motives for doing so. Using lagged multi-level models, the within-person model allows for assessment of individual change in behavior over the two-week time period, as well as the effect of each day?s behavior on behavior occurring on subsequent days. The between-person model allo | At 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04358276 -
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
|
N/A | |
Completed |
NCT01242618 -
Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule
|
Phase 1 | |
Not yet recruiting |
NCT06167096 -
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
|
N/A | |
Recruiting |
NCT03699995 -
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
|
N/A | |
Completed |
NCT04456140 -
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
|
Phase 1 | |
Terminated |
NCT03630601 -
Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers
|
N/A | |
Recruiting |
NCT03543969 -
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
|
Early Phase 1 | |
Completed |
NCT00783965 -
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
|
Phase 2 | |
Recruiting |
NCT04475640 -
Cancer Genetic Testing in Ethnic Populations
|
N/A | |
Active, not recruiting |
NCT02465060 -
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
|
Phase 2 | |
Completed |
NCT02417948 -
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
|
N/A | |
Completed |
NCT03290989 -
Itch and Pain Characteristics in Skin Carcinomas
|
N/A |